Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Feb 11:8:100359.
doi: 10.1016/j.crmicr.2025.100359. eCollection 2025.

Kodamaea ohmeri: An emergent yeast from a One Health perspective

Affiliations

Kodamaea ohmeri: An emergent yeast from a One Health perspective

Sthefany Emanuelle Silva et al. Curr Res Microb Sci. .

Abstract

Kodamaea ohmeri is an emerging and opportunistic yeast associated with a high mortality rate in humans. As it is commonly found in the environment, it is possible that environmental conditions and agricultural practices contribute to the adaptation of this yeast and the selection of antifungal resistance. During a multicentric study in Brazil, conducted under a One Health perspective, 14 isolates of K. ohmeri were identified from different sources: three from blood cultures, three from animals (swine and poultry), and eight from animal environments (swine and poultry). Yeasts were isolated using CHROmagar® Candida medium and identified by MALDI-TOF MS and ITS rDNA barcoding. Minimum inhibitory concentration (MIC) was determined using the broth microdilution method for clinical (azoles, echinocandins, pyrimidine analogs, and polyenes), and environmental antifungals (tebuconazole, pyraclostrobin, carbendazim, and mancozeb), and hospital disinfectants (quaternary ammonium compounds). Of note, color variations of K. ohmeri were noted on CHROmagar® depending on the incubation time, which is likely to complicate its identification. Following polyphasic identification and taxonomic confirmation, all isolates demonstrated low MIC values for clinical antifungals, disinfectants, and tebuconazole. However, all isolates were able to grow in the presence of carbendazim, mancozeb, and pyraclostrobin. Together, these findings highlight the risks associated with the use of environmental azoles, such as tebuconazole, as they may impact non-target fungi of medical importance, but other fungicides do not present the same risk. This is the first study to demonstrate that K. ohmeri, an important emerging yeast in human medicine, can be isolated from various sources, including patients. Although the isolates exhibited low MIC values for clinical antifungals, it is crucial to monitor changes in sensitivity patterns over time in emerging microorganisms to prevent the development of multidrug resistance, which may originate in the environment.

Keywords: Agrochemicals; Cross-resistance; Hospital disinfectants; Yeasts.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Image, graphical abstract
Graphical abstract
Fig 1
Fig. 1
Evolutionary relationships of 24 taxa. ITS rDNA phylogenetic tree of the 14 Kodamaea ohmeri isolates using Maximum Parsimony method. The bootstrap consensus tree inferred from 1000 replicates is taken to represent the evolutionary history of the taxa analyzed. Branches corresponding to partitions reproduced in less than 50 % bootstrap replicates are collapsed.
Fig 2
Fig. 2
Variation of color and aspect of 14 Kodamaea ohmeri isolates on CHROmagar® Candida over time. Overall, after 24 h of incubation, the colonies display a pink or lilac color, with a blue background that may or may not be visible. After 48 h, the color gradually shifts to blue, and after 72 h or more of incubation, the colonies of K. ohmeri become green.

References

    1. Bastos R.W., Freitas G.J.C., Carneiro H.C.S., Oliveira L.V.N., Gouveia-Eufrasio L., Santos A.P.N., Moyrand F., Maufrais C., Janbon G., Santos D.A. From the environment to the host: how non-azole agrochemical exposure affects the antifungal susceptibility and virulence of Cryptococcus gattii. Sci. Total Environ. 2019;681:516–523. doi: 10.1016/j.scitotenv.2019.05.094. - DOI - PubMed
    1. Bastos R.W., Rossato L., Goldman G.H., Santos D.A. Fungicide effects on human fungal pathogens: cross-resistance to medical drugs and beyond. PLoS Pathog. 2021;17(12) doi: 10.1371/journal.ppat.1010073. - DOI - PMC - PubMed
    1. Bureš F. Quaternary ammonium compounds: simple in structure, complex in application. Top. Curr. Chem. 2019;377(3):14. doi: 10.1007/s41061-019-0239-2. - DOI - PubMed
    1. Castelo-Branco D., Lockhart S.R., Chen Y., Santos D.A., Hagen F., Hawkins N.J., Lavergne R., Meis J.F., Le Pape P., Rocha M.F.G., Sidrim J.J.C., Arendrup M., Morio F. Collateral consequences of agricultural fungicides on pathogenic yeasts: A One Health perspective to tackle azole resistance. Mycoses. 2022;65(3):303–311. doi: 10.1111/myc.13404. - DOI - PMC - PubMed
    1. Chakrabarti A., Rudramurthy S.M., Kale P., Hariprasath P., Dhaliwal M., Singhi S., Rao K.L.N. Epidemiological study of a large cluster of fungaemia cases due to Kodamaea ohmeri in an Indian tertiary care centre. Clin. Microbiol. Infect. 2014;20(2):O83–O89. doi: 10.1111/1469-0691.12337. - DOI - PubMed

LinkOut - more resources